Survey of Ophthalmology
Volume 55, Issue 5 , Pages 429-444, September 2010

Wegener's Granulomatosis: Clinical Manifestations, Differential Diagnosis, and Management of Ocular and Systemic Disease

  • Ahmad B. Tarabishy, MD

      Affiliations

    • Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
  • ,
  • Mark Schulte, MD

      Affiliations

    • Division of Rheumatology, Case Western Reserve University, Cleveland, Ohio, USA
  • ,
  • George N. Papaliodis, MD

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
  • ,
  • Gary S. Hoffman, MD

      Affiliations

    • Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA
    • Corresponding Author InformationReprint address: Gary S. Hoffman, MD, Department of Rheumatic and Immunologic Disease, Cleveland Clinic. 9500 Euclid Avenue, Cleveland, OH.

published online 20 July 2010.

Abstract 

Wegener's granulomatosis (WG) is a systemic inflammatory disease whose histopathologic features often include necrosis, granuloma formation, and vasculitis of small-to-medium-sized vessels. WG involves many interrelated pathogenic pathways that are genetic, cell-mediated, neutrophil-mediated, humoral, and environmental. WG most commonly involves the upper respiratory tract, lungs, and kidneys, but has been reported to affect almost any organ. Ophthalmologic involvement is an important cause of morbidity in WG patients, occurring in approximately one-half of patients. The presence of unexplained orbital inflammatory disease, scleritis, peripheral ulcerative keratitis, cicatricial conjunctivitis, nasolacrimal duct stenosis, retinal vascular occlusion, or infrequently uveitis should raise the question of possible WG. A thorough clinical examination, laboratory testing, radiologic imaging, and histologic examination are essential to diagnosing WG and excluding potential mimics. Previously a uniformly fatal disease, treatment with cytotoxic and immunosuppressive agents has greatly improved survival. Treatment-related morbidity is a serious limitation of conventional therapies, leading to numerous ongoing studies of alternative agents.

Key words: Wegener's granulomatosis, vasculitis, ANCA, necrotizing granuloma, sinonasal disease, ocular manifestations of systemic disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Publication of this article is supported by an unrestricted grant from Research to Prevent Blindness. New York, NY.

PII: S0039-6257(09)00314-2

doi:10.1016/j.survophthal.2009.12.003

Survey of Ophthalmology
Volume 55, Issue 5 , Pages 429-444, September 2010